Get startedLog in
    Picture of Samyang Biopharm logo

    0120G0 — Samyang Biopharm Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Samyang Biopharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2025
    December 31st
    Period Length:12 M
    Source:Annual Audited Accounts
    Standards:
    IFRS
    Status:Final
    Net Income/Starting Line2,237
    Depreciation
    Amortisation
    Non-Cash Items915
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital3,675
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities9,774
    Capital Expenditures-6,740
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-759
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-7,500
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-1,026
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash1,490